Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Mahmoud Alhariri: Apixaban in Hemodialysis-Treated Kidney Failure With Newly Diagnosed AF
Mahmoud Alhariri/LinkedIn
May 18, 2026, 16:34

Mahmoud Alhariri: Apixaban in Hemodialysis-Treated Kidney Failure With Newly Diagnosed AF

Mahmoud Alhariri, Senior Attending Physician at Helios Universitätsklinikum Wuppertal, Hypertensiologe at Deutsche Hochdruckliga e.V. DHL, Lipidology Specialist at Deutsche Gesellschaft für Lipidologie e. V. (DGFL), shared a post on LinkedIn about a recent article by Wolfgang C. Winkelmayer et al., published in American Journal of Kidney Diseases, adding:

“Among patients with hemodialysis-treated kidney failure, compared with no anticoagulation, initiation of apixaban soon after newly diagnosed AF was associated with lower risks of ischemic stroke, a composite thromboembolic end point, and all-cause mortality but higher rates of clinically meaningful bleeding.”

Title: Effectiveness and Safety of Apixaban Initiation Following Newly-Diagnosed Atrial Fibrillation in Patients With Kidney Failure on Hemodialysis

Authors: Wolfgang C. Winkelmayer, Kevin F. Erickson, Pascale Khairallah, Mingyue He, Maria E. Montez-Rath, Tara I. Chang, Jingbo Niu

Mahmoud Alhariri

Stay updated on all scientific advances with Hemostasis Today.

AF Anticoagulation Apixaban Blood Cardiology DOACs Health Hematology Hemodialysis-Treated Kidney Failure Hemostasis News Hemostasis Today Ischemic stroke Jingbo Niu Kevin F. Erickson kidney Kidney Failure Mahmoud Alhariri Maria E. Montez-Rath Medicine Mingyue He Pascale Khairallah Tara I. Chang Wolfgang C. Winkelmayer
NewsFeed